Similarities between MEK inhibitor and Novartis
MEK inhibitor and Novartis have 3 things in common (in Unionpedia): Binimetinib, BRAF (gene), MEK inhibitor.
Binimetinib
Binimetinib (MEK162, ARRY-162) is a MEK inhibitor being developed by Array Biopharma to treat various cancers.
Binimetinib and MEK inhibitor · Binimetinib and Novartis ·
BRAF (gene)
BRAF is a human gene that encodes a protein called B-Raf.
BRAF (gene) and MEK inhibitor · BRAF (gene) and Novartis ·
MEK inhibitor
A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.
MEK inhibitor and MEK inhibitor · MEK inhibitor and Novartis ·
The list above answers the following questions
- What MEK inhibitor and Novartis have in common
- What are the similarities between MEK inhibitor and Novartis
MEK inhibitor and Novartis Comparison
MEK inhibitor has 20 relations, while Novartis has 316. As they have in common 3, the Jaccard index is 0.89% = 3 / (20 + 316).
References
This article shows the relationship between MEK inhibitor and Novartis. To access each article from which the information was extracted, please visit: